Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 6, 2022; 10(7): 2072-2086
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2072
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2072
Figure 1 Expression of N-Myc downstream-regulated gene family genes in the Oncomine and The Cancer Genome Atlas databases.
A: messenger RNA (mRNA) expression of N-Myc downstream-regulated gene (NDRG)1, NDRG2, NDRG3, and NDRG4 among various types of cancer using the Oncomine databases. The number in the cells indicate the number of datasets with statistically significant up-expression (red) or down-expression (blue) (cancer vs corresponding normal tissue); B: mRNA expression of NDRG1, NDRG2, NDRG3, and NDRG4 in tumor and normal samples in The Cancer Genome Atlas-liver hepatocellular carcinoma (LIHC) cohort; C: The paired mRNA expression of NDRG1, NDRG2, NDRG3, and NDRG4 between tumor and normal samples in The Cancer Genome Atlas-liver hepatocellular carcinoma cohort; D: The representative protein expression of NDRG members in hepatocellular carcinoma and normal liver tissue from the Human Protein Atlas.
- Citation: Yin X, Yu H, He XK, Yan SX. Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma. World J Clin Cases 2022; 10(7): 2072-2086
- URL: https://www.wjgnet.com/2307-8960/full/v10/i7/2072.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i7.2072